Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check19 days agoChange DetectedA notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the unavailable study record.SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe 403 error page’s footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page no longer shows the 403 Forbidden message or its Home button, leaving the main content area blank beneath the navigation.SummaryDifference0.5%

- Check47 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record with an error screen. As a result, the essential trial information is no longer visible.SummaryDifference16%

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.